RAD101 (18F-FPIA)

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain MetastasesNCT06777433RADXPhase 2Active not recruiting2026-04-23Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.